Publications and Presentations Database
P
LaRusse, S., Katzen, H., Brown, T., Barber, M., Whitehouse, P. J., Green, R. C., et al.
(2002).
Participant recall of their own apolipoprotein E (APOE) genotype and risk estimate after six weeks: Results from the REVEAL Study.
I
Brown, T., Roberts, J. S., LaRusse, S., Barber, M., Relkin, N., Whitehouse, P., et al.
(2002).
Impact of genetic risk assessment for Alzheimer’s disease.
H
Green, R. C., Roberts, J. S., Brown, T. C., Whitehouse, P. J., Barber, M., Relkin, N. R., et al.
(2002).
How many adult children of patients with Alzheimer’s disease will choose genetic susceptibility testing with APOE genotyping?.
Roberts, J. S., Lock, M., Prest, J., Barber, M., Whitehouse, P., LaRusse, S., et al.
(2004).
How does genetic testing affect anxiety about developing Alzheimer’s disease? .
Roberts, J. S., Green, R. C., Nelkin, N., Whitehouse, P., Brown, T., Barber, M., et al.
(2003).
How do participants rate the impact of genetic susceptibility testing for Alzheimer’s disease?.
G
LaRusse, S., Katzen, H, Roberts, J. S., Barber, M., Brown, T., Whitehouse, P., et al.
(2002).
Genetic test results alter perception of risk of Alzheimer's disease: Preliminary results of the REVEAL Study.
Roberts, J. S., Green, R. C., Relkin, N., Whitehouse, P., Brown, T., Barber, M., et al.
(2002).
Genetic susceptibility testing for adult children of patients with Alzheimer’s disease: Participants’ self-reports on the impact of risk assessment.
] 